Safe Use of Medication at Home by Caregivers. Experimental Study

NCT05247801 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 142

Last updated 2025-06-26

No results posted yet for this study

Summary

Experimental study to test the effectiveness of a psychoeducational intervention using virtual reality, aimed at caregivers of multi-pathological and polypharmacy persons to promote safer medication use at home. Experimental design with two groups (experimental and control), pre-post measures, and participants assignment to groups by simple randomization.

Null hypothesis. There will be no differences in the frequency of medication errors at home, the severity of the consequences of medication errors, perceived self-efficacy, and health literacy between caregivers using a dosing device (control group) and caregivers using a dosing device with the reinforcement of a psychoeducational intervention designed ad hoc (experimental group).

Conditions

  • Caregivers of Multi-pathological and Polypharmacy Adults

Interventions

BEHAVIORAL

Psychoeducational intervention for safe medication use at home + Medication dosing device

The intervention is yet to be defined. Psychoeducational intervention based on virtual reality, demonstrations, and psychoeducational content using virtual reality. Contents: Most frequent medication errors at home. Approaches to risk management in the home. Correct use of the most common medications in different patient profiles. Strategies to avoid medication errors. Guidance to alleviate the burden of responsibility suffered by women as a result of the gender bias derived from assuming the caregiver role. Other.

DEVICE

Medication dosing device

Use of medication dosing device.

Sponsors & Collaborators

  • Servicio Aragonés de Salud (SALUD)

    collaborator UNKNOWN
  • Fondo de Investigación en Salud (FIS)

    collaborator UNKNOWN
  • Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunidad Valenciana

    collaborator UNKNOWN
  • Hospital General de Elda

    collaborator OTHER
  • Servicio Navarro de Salud - Osasunbidea

    collaborator UNKNOWN
  • Hospital Universitari Sant Joan d'Alacant

    collaborator UNKNOWN
  • Hospital Universitario San Cecilio

    collaborator UNKNOWN
  • Fundación Pública Andaluza Progreso y Salud

    collaborator OTHER
  • Universidad Miguel Hernandez de Elche

    lead OTHER

Principal Investigators

  • José Joaquín Mira, Ph.D. · Univ. Miguel Hernández; Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la CV

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-04-11
Primary Completion
2024-11-13
Completion
2024-12-12

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05247801 on ClinicalTrials.gov